The market is so dumb. CYCC today is an example. SNSS had bad trial news last night, and that's why it's down over 5%. You would think that would be good for CYCC. CYCC is competing againt SNSS, since they both have phase 3 trials for AML. You'd think with negative SNSS news, investors would move over to CYCC. But instead, CYCC is being punished for SNSS' failure. It's RIDICULOUS. CYCC has had nothing but good trial results. It's hard to believe the stock price is this low. I honestly don't know how much more of this punishment I can take.
Relax you own the winner. All these hired hands on the board are a testament. Always said, SNSS is an accident waiting to happen. Red flag was when they had to increase the size of their study to increase the statistical power. People will not migrate from SAP to their drug in the refractory AML setting. The regimen has some nasty side effects ( Muccocystic oral lesions) and its combined with Cytarybine.